Mitigation of pandemic influenza: review of cost-effectiveness studies. (Q30382889)

21 June 2017

1 reference

title

Mitigation of pandemic influenza: review of cost-effectiveness studies. (English)

1 reference

21 June 2017

0 references

2

Maarten J Postma

1 reference

21 June 2017

Anna K Lugnér

1

1 reference

21 June 2017

1 December 2009

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

21 June 2017

1 reference

21 June 2017

9

1 reference

21 June 2017

6

1 reference

21 June 2017

547-558

1 reference

The epidemiology and clinical impact of pandemic influenza.

21 June 2017

1 reference

Containing pandemic influenza with antiviral agents.

21 January 2018

1 reference

Containing pandemic influenza at the source.

21 January 2018

1 reference

Strategies for containing an emerging influenza pandemic in Southeast Asia

21 January 2018

1 reference

Mitigation strategies for pandemic influenza in the United States.

21 January 2018

1 reference

Antiviral resistance and the control of pandemic influenza

21 January 2018

1 reference

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

21 January 2018

1 reference

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

21 January 2018

1 reference

A taxonomy of model structures for economic evaluation of health technologies.

21 January 2018

1 reference

Cost-benefit of stockpiling drugs for influenza pandemic.

21 January 2018

1 reference

Influenza pandemic preparedness in France: modelling the impact of interventions

21 January 2018

1 reference

Controlling pandemic flu: the value of international air travel restrictions.

21 January 2018

1 reference

Modelling the health-economic impact of the next influenza pandemic in The Netherlands.

21 January 2018

1 reference

Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.

21 January 2018

1 reference

Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply

21 January 2018

1 reference

The economic impact of pandemic influenza in the United States: priorities for intervention.

21 January 2018

1 reference

Estimating the costs of school closure for mitigating an influenza pandemic.

21 January 2018

1 reference

Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.

21 January 2018

1 reference

Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.

21 January 2018

1 reference

Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern.

21 January 2018

1 reference

Anticipating crisis: towards a pandemic flu vaccination strategy through alignment of public health and industrial policy

21 January 2018

1 reference

Strategies for mitigating an influenza pandemic

21 January 2018

1 reference

Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.

21 January 2018

1 reference

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

21 January 2018

1 reference

Do we fully understand the economic value of vaccines?

21 January 2018

1 reference

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

21 January 2018

1 reference

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies

21 January 2018

1 reference

Cost-effectiveness analyses of human papillomavirus vaccination

21 January 2018

1 reference

Antiviral agents for influenza: a comparison of cost-effectiveness data

21 January 2018

1 reference

Economics of stockpiling for an influenza pandemic

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.09.56

1 reference

21 June 2017

1 reference

PubMed ID

19941432